A 64-year-old man from Quebec has become the pioneering recipient of a regenerated liver in North America, thanks to a revolutionary technology with the potential to increase the availability of transplantable livers significantly within its initial year. Gérard Landry, residing in Nouvelle on Quebec’s Gaspé Peninsula, grappled with liver complications for approximately 15 years, eventually leading to cirrhosis and liver cancer.
Before undergoing liver transplant surgery, Landry received surprising news from his doctor regarding the organ – it had been regenerated using a novel machine, utilized for the first time at Montreal’s Centre hospitalier de l’Université de Montréal (CHUM). Landry expressed his joy, likening the news to a Christmas gift.
The innovative technology, known as Liver Assist, enables medical professionals to treat and evaluate a donated liver externally before transplantation. For Landry, this meant receiving an organ that may have been deemed too risky for use otherwise.
Dr. David Hénault, a hepatopancreatobiliary surgeon and liver transplant specialist at CHUM, spearheaded the project and conducted Landry’s surgery. He mentioned that the team had been preparing to implement the technology for about three years.
The Liver Assist system functions by linking a donated liver to a machine that circulates oxygen-rich fluid through the organ, potentially reversing some oxygen deficiency-induced damage while the liver is outside the body. Subsequently, the technology allows a switch to a blood-based solution to assess the liver’s functionality under conditions simulating the human body.
Hénault highlighted that Landry’s received liver was particularly suitable for the technology as it was vulnerable to oxygen deficiency-induced damage during the organ transfer process. The CHUM conducts around 70 liver transplants annually, and a collaborative study with Transplant Québec identified livers previously rejected for transplantation that could be revitalized using the new technology.
The team approximates that the machine could make an additional 20 to 24 livers available for transplant in its inaugural year, with potential growth as the technology becomes more widespread. Hénault emphasized the positive impact on patients awaiting liver transplants, anticipating enhanced outcomes with reduced complications, reoperations, and hospital stays for suitable candidates.
Landry’s recovery progress post-surgery exceeded expectations, with his blood work showing promising results shortly after the operation. Hénault credited the technology for aiding in Landry’s successful transplant.
Currently recovering in Montreal, Landry undergoes periodic blood tests at the hospital for medication adjustments. With aspirations to return to Gaspésie post-recovery, Landry eagerly anticipates reuniting with his family, grandson, friends, and horses.
He also hopes his experience will spur conversations about organ donation, emphasizing the crucial role of donated organs in medical advancements. Landry’s analogy underscores the necessity of donated organs, stating, “if you have a horse without a rider, you don’t have a ride.”